PICK1 and neuropathic pain: Also, the small‐molecule inhibitor of PICK1 FSC231 (Thorsen et al, 2010) as well as a myristoylated GluA2 inhibitory peptide (Garry et al, 2003) failed to elicit a significant effect on the PWT (Fig EV4B and C), whereas gabapentin, a first‐line treatment for neuropathic pain, reversed PWT to baseline levels of the contralateral paw and prior to nerve injury of the ipsilateral paw (Fig EV4D).